MTOR and renal carcinoma: Interestingly, we have demonstrated that the CNI-induced VEGF overexpression and renal cancer cell proliferation is inhibited by RAPA treatment, suggesting the possible role of mTOR in CNI-induced tumorigenic pathways that involves Ras activation [23], [24].